Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting

MLA

Tetsuya Matoba, et al. “Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting.” JACC: Cardiovascular Interventions, vol. 14, Nov. 2021, pp. 2330–40. EBSCOhost, https://doi.org/10.1016/j.jcin.2021.07.045.

APA

Tetsuya Matoba, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Masato Nakamura, Katsumi Miyauchi, Nobuhisa Hagiwara, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa, Yukihiro Koretsune, Takafumi Hiro, Tetsuya Sumiyoshi, Kazumi Kimura, Yoichiro Hashimoto, Teruyuki Hirano, Hiroyuki Daida, … H. Mori. (2021). Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting. JACC: Cardiovascular Interventions, 14, 2330–2340. https://doi.org/10.1016/j.jcin.2021.07.045

Chicago

Tetsuya Matoba, Satoshi Yasuda, Koichi Kaikita, Masaharu Akao, Junya Ako, Masato Nakamura, Katsumi Miyauchi, et al. 2021. “Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting.” JACC: Cardiovascular Interventions 14 (November): 2330–40. doi:10.1016/j.jcin.2021.07.045.